Re-imagining data capture
Technology is in many ways a fitting enabler for behaviour change, and a valuable resource to influence habits. However, most quantified-self tools, wearables and self-improvement apps often have a short shelf life. To give an example, over 50% of consumers give up on using their wearable devices after 6 months, and 80% of health app users abandon them after just 14 days.
Whilst there are a variety of reasons for typically short-term user engagement, data capture is one of the most commonly reported barriers. Data logged manually through apps or websites is often too tedious for continual adoption, and data captured seamlessly through wearables can be easy to ignore and consequently eliminates the catalyst for genuine self-improvement, for example. In order to effect long term behaviour change at a global scale we need to imagine new ways of engaging audiences. For self-tracking to make the leap from early adopters to the mainstream public, the barrier to participation needs to be removed.
This challenge, therefore, seeks innovative means of recording data relevant to quantified-self for wellbeing applications. The successful solution must achieve one or more of the following:
- Reinvent familiar technologies, feedback mechanisms and interfaces; such as text messaging, haptic feedback, and voice interface
- Implement emerging technologies, such as augmented reality, into tangible products and services.
- Enable more "sensorial" experiences, such as using voice or images.
Additionally, applicants may wish to explore alternative types of data capture as a means of understanding the users' context, taking a more holistic view of wellbeing beyond hard, objective data like blood pressure or caloric intake.
The successful company will trial their solution with Bupa for a minimum period of three months before being commercialised more widely. Bupa will provide expertise to the winning company, as part of their current or future behaviour change interventions and activities, as well as provide access to users/customers where appropriate. Additional support will be available through Bupa's GLIDHE programme; the Global Institute for Digital Health Excellence.
Bupa is a leading global health and care company with unique breadth, scale, influence and expertise. Our aim is to improve and engage millions of people in their health and wellbeing across the globe. We serve 29 million customers in more than 190 countries, and employ almost 80,000 people world-wide. We deliver a broad range of services to fund and provide healthcare. Our status as a private company, limited by guarantee, means we have no shareholders and are not driven by short-term profit. This means we behave commercially and focus on our customers, whilst taking a long-term view and reinvesting our profit to provide more and better healthcare, fulfilling our purpose: longer, healthier and happier lives. We believe integrated healthcare, with all parts of the healthcare system working together, is the future of healthcare delivery. With our expertise, we deliver this in a number of our markets.
GLIDHE, the Global Institute for Digital Health Excellence, is a partnership between Bupa and UCL established in 2015 with the intention of reducing global demands on healthcare and improving quality of life. GLIDHE researches, creates, tests and evaluates innovative, commercially sustainable digital tools which promote healthier lifestyles. The aim is to improve the lives of millions of people and create a significant evidence base to shape the future of digital health. Through this partnership, we are combining Bupa's global health expertise with UCL's world leading behaviour change and computer science capabilities, so we have a fantastic opportunity to develop scalable tools that are proven to genuinely help people to adopt healthier habits and reduce their risk of chronic disease in the future.